高级检索
当前位置: 首页 > 详情页

The correlation between serum contents of TGF-beta 1 and IL-6 and acute radiation pneumonitis in patients with lung cancer

文献详情

资源类型:
WOS体系:

收录情况: ◇ ESCI

机构: [1]Lung Tumor Unit, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan Province, 610041, China
出处:
ISSN:

关键词: Non-small cell lung cancer Radiation pneumonitis Transforming growth factor beta 1 Interleukin-6

摘要:
Objective: To explore the correlation between contents of serum transforming growth factor beta 1 (TGF-beta 1) and interleukin-6 (IL-6) and acute radiation pneumonitis (RP) in patients with lung cancer. Methods: A total of 138 patients with non-small cell lung cancer receiving threedimensional conformal radiation therapy in our hospital from May 2012 to October 2015 were selected as the research objects. According to the presence or absence of RP in the process of radiotherapy, those patients were divided into the RP group and non RP group to detect the contents of TGF-beta 1 and IL-6 in serum. Results: Before radiotherapy, there was no significant difference in the serum contents of TGF-beta 1 and IL-6 in the RP group and non RP group. At weeks 2, 4, 6, 8 and 10 after radiotherapy, the serum contents of TGF-beta 1 and IL-6 in patients of the RP group were all higher than those in the non RP group. Differences of the contents of TGF-beta 1 and IL-6 in each time point after radiotherapy between two groups had statistical significance (P < 0.05). In RP group, the higher the RP grade was, the more the serum contents of TGF-beta 1 and IL-6 became. Differences of the contents of TGF-beta 1 and IL-6 in patients with different RP grade were statistically significant in each time point (P < 0.05). Conclusions: In the process of radiotherapy, the increase of the serum contents of TGF-beta 1 and IL-6 in patients with lung cancer is closely related to the occurrence of acute RP.

基金:
语种:
被引次数:
WOS:
JCR分区:
出版当年[2016]版:
最新[2023]版:
Q4 CRITICAL CARE MEDICINE

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2015版]

第一作者:
第一作者机构: [1]Lung Tumor Unit, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan Province, 610041, China [*1]Lung Tumor Unit, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan Province, 610041, China.
通讯作者:
通讯机构: [1]Lung Tumor Unit, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan Province, 610041, China [*1]Lung Tumor Unit, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan Province, 610041, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43378 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号